Skip to main content

Table 1 Main characteristics of the included studies (nĀ =Ā 5)

From: Enhanced recovery after liver surgery in cirrhotic patients: a systematic review and meta-analysis

Study

Country

Design

Type of surgery

Total n of patients

Cirrhotic patients

Age (y, median)

Men, n (%)

CPT A, n (%)

Diagnosis

Major hepatectomy, n (%)

Ā 

ERAS

CTL

ERAS

CTL

ERAS

CTL

ERAS

CTL

Ā 

ERAS

CTL

Gonvers et al. 2020

Switzerland

NRS

Lap. and open

541

21 (47%)

24 (53%)

64

64.5

17 (81)

21 (87)

N/a

N/a

HCC: 32 (71)

Other: 13 (29)

7 (33)

11 (46)

Lunel et al. 2021

France

NRS

Lap. and open

430

59 (56%)

46 (44%)

67

65

54 (91.5)

44 (95.7)

55 (93)

45 (98)

HCC: 96 (91)

Other: 9 (9)

14 (24)

9 (19)

Qi et al. 2018

China

RCT

Lap. and open

160

80 (50%)

80 (50%)

53.7

55.4

47 (58.8%)

40 (50)

8 (10)

13 (16)

Liver tumor: 68 (43)

Other: 92 (57)

28 (35)

31 (39)

Zheng et al. 2020

China

NRS

Lap. and open

114

80 (49%)

82 (51%)

55

59

64 (80)

59 (72)

80 (100)

82 (100)

HCC: 114 (100)

30 (38)

21 (26)

Zhou et al. 2021

China

NRS

Lap.

174

87 (50%)

87 (50%)

54.9

55.2

66 (75.9)

70 (80.5)

N/a

N/a

HCC: 174 (100)

5 (6)

1 (1)

  1. NRS Non-randomized study, RCT Randomized clinical trial, Lap laparoscopic, CTL Control, CPT Child-Turcotte-Pugh, N/a Not available, HCC Hepatocellular carcinoma. Diagnoses are given to cirrhotic patients only. Other diagnoses were hepatolithiasis (nĀ =Ā 92), Colorectal metastasis (nĀ =Ā 5), adenoma nĀ =Ā 2), hepatic cyst (nĀ =Ā 1), hemangioma (nĀ =Ā 1), Caroli disease (nĀ =Ā 1), micronodular cirrhosis (nĀ =Ā 1), right liver atrophy (nĀ =Ā 1), not specified (nĀ =Ā 9). Qi et al. did not specify the type of liver tumor